Neuronetics, Inc. engages in providing in office treatments for patients with neurohealth disorders in the United States and internationally. The company offers NeuroStar Advanced Therapy System, a non-invasive and non-systemic office-based treatment to treat adult patients with major depressive disorder. Its NeuroStar Advanced Therapy System uses transcranial magnetic stimulation to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The company sells its products through its sales and customer support team to psychiatrists. The company was incorporated in 2001 and is headquartered in Malvern, Pennsylvania. Show more

3222 Phoenixville Pike, Malvern, PA, 19355, United States

Medical Devices
Healthcare
Start AI Chat

Market Cap

84.92M

52 Wk Range

$1.20 - $5.92

Previous Close

$1.24

Open

$1.21

Volume

705,802

Day Range

$1.21 - $1.30

Enterprise Value

246.1M

Cash

28.15M

Avg Qtr Burn

-785K

Insider Ownership

19.13%

Institutional Own.

61.74%

Qtr Updated

09/30/25


Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.

Drug & IndicationStage & EventCatalyst Date